ArticleFrontiers in oncology2026
A comprehensive treatment analysis of primary squamous cell carcinoma of the prostate with inguinal lymph node metastasis: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Primary squamous cell carcinoma(SCC) of the prostate is a rare clinical condition, characterized by diagnostic challenges in the early stages, a high potential for metastasis, considerable malignancy, and a poor prognosis. Reporting such cases may contribute to a better understanding of the pathogenesis and clinical manifestations of prostatic SCC, as well as facilitate the exploration of diagnostic approaches and effective treatment strategies. Case presentations: A retrospective analysis was conducted on the clinical case of a 62-year-old male patient with primary prostatic SCC and concurrent inguinal lymph node metastasis, admitted to our institution. The diagnosis was confirmed by histopathological examination following fine-needle aspiration biopsy. The patient underwent two cycles of intravenous chemotherapy, followed by radical surgical resection and adjuvant radiotherapy. By integrating findings from this case with current literature, this study aims to elucidate the etiology, clinical manifestations, diagnostic strategies, therapeutic modalities, and prognostic factors associated with this rare malignancy. Conclusion: The patient demonstrated good tolerance to both chemotherapy and radiotherapy, with a significant reduction in lesion size observed following treatment. After comprehensive management including surgical resection, the patient has remained alive for nearly two years of continuous follow-up. Notably, prostatic SCC exhibits poor responsiveness to endocrine therapy. The most effective therapeutic approach involves early radical surgery, which, when integrated with chemotherapy, radiotherapy, and other modalities, may contribute to prolonged survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.